Two sites within the short region origin of DNA replication (oris) in herpes simplex virus type 1 (HSV-1) which bind the product of the UL9 gene have previously been identified. One of these sites (site I) contains an 11 bp sequence which is also present in oris of varicella-zoster virus, and the other (site II) includes a related element differing in two positions. A third sequence (motif III), which lies close to binding site I, differs from the site I element at only a single position. We have deleted specifically each of these three 11 bp sequences from within functional copies of HSV-1 oris and have examined the effects on origin activity and binding of the UL9 protein. Gel retardation analyses confirmed the important roles of the regions deleted from sites I and II in interacting with the UL9 protein.
Introduction
The herpes simplex virus type 1 (HSV-1) genome is a large double-stranded DNA of approximately 152 kbp which encodes at least 70 distinct polypeptides (McGeoch et al., 1988a) . Three origins of DNA replication have been located in two distinct regions of the genome, namely oriL, which lies close to the centre of the long unique region (UL), and oris which is present, in two copies, in the inverted repeats TRs and IRs ( Fig. 1 ) (Spaete & Frenkel, 1982; Mocarski & Roizman, 1982; Stow & McMonagle, 1983 : WeUer et al., 1985 .
Determination of the sequence requirements for origin activity has utilized a transient replication assay based upon the observation that plasmid DNAs containing functional viral origins are replicated in transfected tissue culture cells superinfected with HSV-1 (Stow, 1982) . Initial studies identified a 90 bp segment which specified ori s activity and included a 45 bp near-perfect palindromic DNA sequence with an AT-rich central region (Stow & McMonagle, 1983) . OriL activity was shown to be encoded by a fragment containing a longer palindromic sequence of 144 bp (Weller et al., 1985) . The two origins nevertheless exhibit high sequence similarity covering the region of the oris palindrome together with approximately 40 bp to one side.
Recent studies have identified a set of seven HSV-1 genes which encode proteins necessary and sufficient for viral DNA synthesis (Wu et al., 1988; McGeoch et al., 1988b ; reviewed by Challberg & Kelly, 1989) . One of these proteins, encoded by the UL9 gene, binds to specific sequences within the origin regions (Olivo et al., 1988; Weir et al., 1989) . DNase footprinting and gel retardation studies demonstrated that the UL9 protein binds to two sites within ori s which overlap the ends of the palindromic DNA sequence ( Fig. 1) (Elias & Lehman, 1988; Koff & Tegtmeyer, 1988; Olivo et al., 1988; Weir et al., 1989) . The results of methylation interference and site-directed mutagenesis experiments indicate that the UL9 recognition sequence comprises, or is included within, YGYTCGCACT (where Y represents C or T) (Koff & Tegtmeyer, 1988; Deb & Deb, 1989) . Interestingly this sequence is contained within an 11 bp motif (CGTTCGCACTT) which was previously shown to be conserved in the replication origins of HSV-1 and varicella-zoster virus (VZV) (Stow & Davison, 1986) .
A key question concerns the importance of the UL9 binding sites for origin activity. Recent fine mapping of the core sequences comprising the very closely related ori s of herpes simplex virus type 2 (HSV-2) identified an essential region of 75 bp, depicted in Fig. 1 (Stow & McMonagle, 1983) . The insert in plasmid pST19 extends an additional 10 residues at the right. The two binding sites identified by Elias & Lehman (1988) are boxed and the 45 bp palindrome is indicated by arrows. The core origin sequence identified by Lockshon & Galloway (1988) is contained between the broken vertical lines. Del I, del II and del III indicate the 11 bp deletions introduced into plasmid pST19. (c) Alignment of the three deleted sequences. The sequences from binding site II and motif III are represented in the opposite orientation from (b). Differences are indicated by crosses and the point mutation introduced into oligonucleotide mI and plasmid pST19pmI corresponds to the difference between the del I and del III (motif lID sequences.
Galloway, 1988). Removal of 7 bp from the left of this sequence, or 4 bp from the right, caused a great reduction in activity (Lockshon & Galloway, 1988) . This result suggests that an intact binding site II may be essential for efficient origin function, in addition to sequences which lie to the left of binding site I. Examination of the sequence in the latter location reveals the presence of an 11 bp sequence differing in only one position from the presumed UL9 protein recognition sequence within binding site I. This sequence is labelled motif III in Fig. 1 . Conflicting results on the importance of binding site II were presented by Deb & Doelberg (1988) who reported that a 67 bp origin fragment completely lacking site II replicated as efficiently as the 100 bp parental fragment. However, when a 6 bp deletion was introduced into the region specifying binding site I replicative ability was lost (Deb & Deb, 1989) . The results from these workers thus suggest that site I but not site II is important for origin activity.
In this report we have examined whether the UL9 protein can bind to motif III, and, by using site-directed mutagenesis, have investigated the roles of binding sites I and II and sequence motif III in origin activity. Our results indicate that the presence of both sites I and II is necessary for efficient origin activity, and, although it does not function as a UL9 binding site, motif III may play some auxiliary role.
Methods
Cells and virus. Baby hamster kidney (BHK 21 C13) cells were grown in Eagle's medium supplemented with 10% tryptose phosphate broth and 10~ calf serum (Macpherson & Stoker, 1962) . Subconfluent cell monolayers (2 × 106 cells/50 mm plastic Petri dish) were used for DNA transfections and the superinfecting virus was wild-type HSV-1 (Glasgow strain 17).
Oligonucleotides and DNA fragments. The 100 bp BamHI plus Sail oris-containing fragment from plasmid pS19 (Stow & McMonagle, 1983) was cloned between the corresponding sites of pTZ 19U (Mead et al., 1986) to yield plasmid pSTI9.
The synthesis, purification and annealing of complementary singlestranded oligonucleotides and their subsequent end-labelling were performed as previously described (Weir et al., 1989) . The following duplex oligonucleotides were used:
Oligonucleotides I and mI contain the binding site I sequence, a single base pair change having been introduced into mI at the underlined position. Oligonucleotide III contains the motif III sequence (Fig. I b) . The alignment of the conserved elements within oligonucleotides 1 and III is shown in Fig. 1 
(c).
Oligonucleotide-directed mutagenesis. Specific deletions and point mutations were introduced into the pST19 oris-containing fragment essentially as described by Mead et al. (1986) and Kunkel (1985) . Escherichia coli BW313 was transformed with the parental plasmid and uracil-rich single-stranded DNA was prepared by infecting cultures grown in 0.25 mg/ml uridine with phage M13 R408 at an m.o.i, of 10. Single-stranded DNA was precipitated with 0.25 vol. of 3-5 Mammonium acetate, 20% polyethylene glycol 6000, extracted with phenol/chloroform and reprecipitated with ethanol. The appropriate mutagenic oligonucleotides were 5' phosphorylated and annealed to the complementary single-stranded DNA at a molar ratio of 10 : 1. Double-stranded DNA was synthesized using the Klenow fragment of DNA polymerase I and T4 DNA ligase in the presence of 100 ~tM-dNTPs, 1 mr, l-ATP and 100 p.g/ml gene 32 protein. The reaction was incubated 18 h at 15 °C and the products used to transform E. coli DH1 to ampicillin resistance. Plasmids carrying the desired mutations were identified by sequencing the complete insert as described by Hattori & Sakaki (1986) .
Oligonucleotides used for the introduction of 11 bp deletions contained 14 or 15 bases from each side of the sequence to be deleted. The introduction of the point mutation into site I was performed using a 20-mer. The resulting plasmids pST19dell, pSTl9delll and pST19dellIt respectively contain 11 bp deletions affecting binding site I, binding site II and motif IH (see Fig, 1 ). Plasmid pST19pmI contains a G to T change at the indicated position within binding site I (Fig. 1) .
Transient replication assays. Plasmid replication assays were performed as previously described (Stow & McMonagle, 1983) except that monolayers each received quantities of plasmid DNA which were the molar equivalent of 0.25 ~tg pTZ19U. Total cellular DNA, prepared from mock-infected and superinfected cells, was digested with EcoRI in the presence of DpnI to remove any signal resulting from the presence of unreplicated input plasmid DNA (DNA synthesized in eukaryotic cells contains unmethylated Dpnlrecognition sites and is consequently resistant to digestion by this enzyme). Agarose gel electrophoresis, Southern blotting and-hybridization to 32p-labelled DNA of the vector pAT153 were as previously described (Stow & McMonagle, 1983) .
Gelretardation analysis. Gel retardation experiments were performed as described by Weir et al. (1989) except that complex formation was analysed on 8~ polyacrylamide gels. Origin binding activity was detected with a fusion protein encoded by plasmid pB1 and expressed in E. coli which consists of the C-terminal 317 amino acids of the UL9 protein (containing the sequence-specific DNA-binding domain) attached to 260 amino acids from the N terminus of the Staphylococcus aureus Protein A (Weir et al., 1989) . Extracts from heat-induced bacteria expressing this activity (KB1 extract) and from control bacteria expressing only the Protein A region (KR2 extract) were prepared as previously described (Weir et al., 1989) .
Results

UL9 protein binding sites I and H are required for efficient ori s activity
In order to assess the role of the UL9 protein binding sites in HSV-1 ori s activity, specific mutations were introduced into cloned copies of a functional origin. Oligonucleotide-directed mutagenesis was used to delete 11 bp sequences from within the previously identified UL9 protein binding sites (sites I and II) and to remove a closely related sequence (motif III) which lies adjacent to binding site I (Fig. 1) . The three sequences deleted are closely related to each other and to an 11 bp element present in oris of VZV (Stow & Davison, 1986 ). In addition they include nucleotides which, in the case of site I, have previously been shown to play important roles in binding of the UL9 protein (Koff & Tegtmeyer, 1988; Deb & Deb, 1989) . The identities of the resulting plasmids pST19delI, pST19delII and pST19delIII, which contain 11 bp deletions affecting binding site I, binding site II and motif III respectively, were confirmed by DNA sequencing. The activities of the mutated viral origins were compared with those of the parental plasmid, pST19, and the vector pTZI9U. Plasmids were transfected into BHK cells which were subsequently either mockinfected or superinfected with HSV-1 to provide helper functions. Samples of DNA extracted from the cells were cleaved with EcoRI plus DpnI and the presence of replicated (DpnI-resistant) plasmid molecules detected by Southern blotting using 32p-labelled pAT153 DNA as probe. (pAT153 efficiently detects DNA sequences of the pTZ family of vectors since these plasmids contain the same ampicillin resistance genes and plasmid origins of DNA synthesis.) The results are shown in Fig. 2 .
As expected, HSV-l-encoded functions facilitated the replication of pST19 but not pTZ19U. Replication of pST19dellII was slightly impaired and pST19dellI more greatly impaired in comparison to pST19. No pST19delI replication products were detectable. To compare the activities of the mutant origins, regions of the nitrocellulose filters corresponding to the positions of the replicated plasmid molecules detected by autoradiography were excised and the radioactivity present was determined in a scintillation counter. Assigning a value of 100~ to the activity of pST19, we obtained corresponding values of 46~, 44~ and 36~ for pSTl9dellII, and 7-0~, 7.7~ and 4-3~ for pST19dellI in independent repeat experiments. On no occasion was pST19delI replication detectable by autoradiography, and comparison of autoradiographs exposed for various times indicated that the activity of this plasmid must therefore be <0.1 ~ of the activity of pST19. These results show that the removal of corresponding 11 bp elements from binding sites I and II causes quantitatively different effects; disruption of site I abolishes detectable activity but significant residual origin function remains when site II is altered. Nevertheless, in contrast to the results of Deb & Doelberg (1988) , we find that the presence of sequences from within binding site II is required for maximum activity. Although removal of motif III had the smallest effect, this element also appears to play some role in enabling efficient replication.
Binding of the UL9 polypeptide to mutated copies of oris
Gel retardation assays were performed to examine the interactions of the UL9 polypeptide with the mutated copies of oris described in the previous section. Extracts from bacteria expressing a fusion protein which contains Fig. 4 . Gel retardation analysis of binding of the UL9 fusion protein to labelled oligonucleotides. Oligonucleotides I, III and mI were endlabelled to comparable specific activities and incubated with KB1 extract either in the absence (lanes 1) or presence (lanes 2) of a 100-fold molar excess of unlabelled oligonucleotide I. Complexes were analysed on an 8~ non-denaturing polyacrylamide gel. the sequence-specific DNA-binding domain of the UL9 polypeptide were used as the source of binding activity because, in contrast to extracts containing the complete UL9 product, they generate protein-DNA complexes which migrate as discrete bands on non-denaturing polyacrylamide gels (Weir et al., 1989) . The viral inserts from plasmids pST19, pST19delI, pST19delII and pST19delIII were released by digestion with BamHI plus Sail, 32p-labelled and purified. Labelled probe fragments were incubated with KB 1 extract, which contains the fusion protein, or the control extract (KR2), and the resulting complexes resolved on a polyacrylamide gel. Fig. 3 shows that labelled retarded complexes were obtained only with the KB1 extract and that in each instance the presence of an excess of unlabelled oligonucleotide containing binding site ! inhibited their formation. Two major retarded complexes were produced with both the pST19 and pST19delIII probes, but only a single major complex with pST19delI and pST19delII (indicated by arrowheads). The fainter bands visible in lanes 2 probably result from the presence Gel retardation analysis using end-labelled BamHI plus SalI insert fragments of plasmids pSTI9 and pST19pmI. Labelled DNA fragments were incubated with KR2 extract (lanes 1) or KBI extract (lanes 2) and the resulting complexes analysed as described in Fig. 3 . The major complexes are indicated by arrowheads.
of a small amount of partially degraded fusion protein in the extract. These results indicate that interaction of the UL9 protein with binding sites I and II is disrupted by the introduction of 11 bp deletions at these locations. In contrast, the protein-DNA interactions within the origin region are not significantly altered in the absence of motif III. ARhough deletion of binding site I abolished detectable oris activity it is clear that the mutated origin retains the ability to bind the UL9 protein.
Failure of the UL9 protein to bind to motif III and to a copy of binding site I containing a specific point mutation
Results presented in the previous sections indicated that the absence of motif III results in a small but reproducible decrease in replicative ability but no apparent alteration in the number of UL9 protein binding sites in the origin region. To examine whether, in the absence of other otis sequences, the UL9 protein might interact with motif III, a duplex oligonucleotide containing this sequence was synthesized and used as a probe in gel retardation assays. Because motif III and the corresponding 11 bp sequence within binding site I differ at only a single nucleotide the effect of introducing this alteration into site I was also examined. KB 1 extract was incubated with 32p-labelled oligonucleotides either in the absence or presence of excess unlabelled oligonucleotide I containing the unmutated binding site I sequence. DNA protein complexes were resolved on a polyacrylamide gel (Fig. 4) . Sequencespecific binding to oligonucleotide I was readily detected but no complexes were observed using either oligonucleotide III or oligonucleotide mI as probe. This result demonstrates that the failure to detect binding to motif III when using an intact oris region as probe is not a consequence of interference caused by protein bound to site I. Rather the replacement by a T residue of the G found at the corresponding position within binding site I is sufficient to abolish interaction with the UL9 protein.
A point mutation within binding site I abol&hes replicative ability
Since a single point mutation within binding site I resulted in failure to bind the UL9 protein, the effect of this alteration on origin activity was also examined. The mutation was introduced into plasmid pST19 using an appropriate oligonucleotide as previously described. The replicative ability of the resulting plasmid pST19pmI was compared with the parental plasmid, pST19 and plasmids pST19delI and pST19delII. Fig. 5(a) shows that the introduction of the point mutation within binding site I was as effective as the 11 bp deletion in eliminating ori s activity. As expected, when 32p_labelled pST19pmI fragment was used as a probe in a gel retardation assay only a single major complex was formed upon incubation with KB1 extract (Fig. 5b) .
Discussion
The experiments presented in this paper aimed to investigate the role in HSV-1 otis activity of the UL9 protein interacting with two previously characterized binding sites. Our results show that whereas plasmids lacking a functional binding site I exhibit no detectable origin activity, the ability of the UL9 protein to bind to site II is not absolutely essential for oris function.
The obligatory requirement for site I is in agreement with results of Deb & Deb (1989) who showed that a plasmid containing a 6 bp deletion affecting this site was inactive in both UL9 binding and replication. Our observation that plasmids in which binding site I has been inactivated by either an 11 bp deletion or a single point mutation exhibit the same behaviour in replication assays strongly suggests that the abolition of origin function is directly related to the failure of UL9 protein to bind to this site and not to alterations in the spacing of other elements within otis. The position of the inactivating point mutation within site I corresponds to one of the two bases within the UL9 protein recognition sequence at which inverted pentanucleotide sequences [GT(T or G)CG] partially overlap (Koff & Tegtmeyer, 1988) . Moreover, the G within the wild-type sequence represents an essential contact residue identified by methylation interference footprinting (Koff & Tegtmeyer, 1988) . Taken together the data indicate that this base pair plays a key role in the sequence-specific interaction with the UL9 protein.
Conflicting results have previously been presented concerning the role of site II in HSV oris activity. Deb & Doelberg (1988) reported that a truncated oris which lacked the entire binding site II region functioned as efficiently in transient replication assays as the intact version. In contrast, when defining the minimum sequence requirement for the almost identical Otis of HSV-2, Lockshon & Galloway (1988) found that removal of only a portion of binding site II virtually abolished activity. Our experiments show that although the lack of a functional binding site II results in significantly reduced replication the presence of two binding sites is not an obligatory requirement for oris activity. This conclusion is supported by previous observations that HSV-encoded helper functions are able to activate oris of VZV with approximately 5~ the efficiency of HSV-1 oris (Stow & Davison, 1986) . The former viral origin contains sequences homologous to known UL9 binding sites adjacent to only one arm of the palindromic sequence (i.e. a binding site I but no binding site II equivalent). The reasons for the apparent discrepancies between the results obtained with the various HSV oris plasmids are unclear but may possibly include differences in virus strains, cell types or experimental protocols.
There is nevertheless a good correlation between our observation that copies of HSV-1 ori s lacking functional site I or site II elements respectively exhibit undetectable or residual origin activity and measurements of the affinity of the UL9 protein for these sites. The latter studies demonstrated that the intrinsic affinity of the UL9 protein is approximately 10-fold greater for site I than for site II (Elias & Lehman, 1988 ; H. M. Weir, unpublished results), The UL9 protein would therefore be expected to bind more tightly to an oris lacking site II than to one lacking site I, and this might be sufficient to account for the residual function of the former origin.
Attempts to define the left-hand boundary of a minimal HSV oris indicated a requirement for an approximately 20 bp region adjacent to binding site I and distal to the palindromic sequence (Lockshon & Galloway, 1988) . Because this region contains an almost perfect inverted repeat of site I (which we have referred to as motif III) it was suggested that this might represent another binding site for the UL9 protein. Gel retardation assays performed with oligonucleotide III (Fig. 4) show that UL9 protein does not interact with this sequence, consistent with the results of DNase I footprinting experiments performed with increasing amounts of UL9 protein (Elias & Lehman, 1988; Olivo et al., 1988) . Moreover our results exclude the possibility that binding to this region had not previously been detected because of the presence of the neighbouring site I.
Although motif III does not bind the UL9 protein, its deletion nevertheless resulted in a reproducible reduction in oris activity of two-to threefold (e.g. Fig. 2 ). In contrast Lockshon & Galloway (1988) showed that an HSV-2 oris deletion mutant (pS207) with an endpoint located within motif III was almost completely inactive in replication assays. These data suggest the possibility that the sequence TAAAAG which abuts motif III and is present in both the core origin sequence of Lockshon & Galloway (1988) and pSTl9dellII but lacking from pS207 may have an important function. A possible explanation for the relatively small decrease in oris activity following deletion of motif III may be that the TAAAAG sequence and the adjacent GC-rich element are brought 11 bp closer to the palindromic DNA sequence.
To date no HSV variants which lack both copies of oris have been reported. This has been interpreted as indicating either that virus replication requires at least one functional cis-acting Otis, or that attempts to inactivate the origin may also have had a deleterious effect on the expression of some essential trans-acting gene product (Hubenthal-Voss et al., 1987; HubenthalVoss & Roizman, 1988) . The recognition that Otis function can be inactivated by a single point mutation (e.g. in plasmid pST19pmI) may facilitate the resolution of this question~
